These include: Fatty liver disease Chronic Fatigue Syndrome Toxic Overload, Including Mold Toxicity Recovery from Stroke and Brain Injury/Trauma Autoimmune Disease Neurodegenerative Disorders, Including Parkinsons, Alzheimers Disease, Dementia, and Memory Loss High Cholesterol and Heart Disease Neuropathy and Other Nerve Disorders Migraines Ulcerative Colitis/Inflammatory Bowel Disease Skin Issues, Including Eczema and Acne PMS Anxiety and Other Mood Disorders Premature Aging Do phosphatidylcholine IVs really work
Effects of Delta-Sleep-Inducing Peptide on 24-Hour Sleep-Wake Behaviour in Severe Chronic Insomnia
In women with polycystic ovary syndrome, supplementation may reduce body mass (68) , and improve mental health parameters and biomarkers of oxidative stress (2)
Or the first step in something much bigger
Thus, liraglutide can be considered an intermediate-acting GLP-1RA providing continuous exposure of the GLP-1 receptor throughout the day, but with clear daily peak and trough plasma concentrations apparently preventing tachyphylaxis on small intestinal motility (32) (Figure 3)
Comparison of effects of SGLT-2 inhibitors and GLP-1 receptor agonists on cardiovascular and renal outcomes in type 2 diabetes mellitus patients with/without albuminuria: a systematic review and network meta-analysis
